Reversal of Warfarin-Associated Life-Threatening Bleed With an Attenuated Dose of 4-Factor Prothrombin Complex Concentrate

Abstract

Get full access to this article

View all access options for this article.

References

Sarode

Milling

Jr Refaai

et al . Efficacy and safety of a four-factor prothrombin complex concentrate (4F-PCC) in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-1243.

Frontera

Lewin

III Rabinstein

et al . Guideline for reversal of antithrombotics in intracranial hemorrhage. Neurocrit Care. 2016;24:6-46.

Goldstein

Refaai

Milling

Jr et al . Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385:2077-2087.

Butler

JJ.

Use of low-dose prothrombin complex concentrate before lumbar puncture. Am J Health Syst Pharm. 2015;72:203-205.

Quick

Meyer

Coughenour

Barnes

SL.

Less is more: low-dose prothrombin complex concentrate effective in acute care surgery patients. Am Surg. 2015;81:646-650.

Kang

Hyun

JJ.

Preparation and patient evaluation for safe gastrointestinal endoscopy. Clin Endosc. 2013;46:212-218.